<DOC>
	<DOCNO>NCT01845649</DOCNO>
	<brief_summary>The purpose study determine WC3011 safe effective treat symptom painful intercourse secondary vulvovaginal atrophy measure subject self-assessment compare vehicle .</brief_summary>
	<brief_title>Study Evaluate Safety &amp; Efficacy WC3011 Postmenopausal Women With Dyspareunia</brief_title>
	<detailed_description />
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Dyspareunia</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Sexually active selfidentified dyspareunia ( pain sexual activity ) , least moderate severe &amp; bothersome symptom VVA ( vulvovaginal atrophy ) Postmenopausal &amp; meet 1 follow : 12 month spontaneous amenorrhea , 6 month spontaneous amenorrhea FSH ( follicle stimulate hormone ) &gt; 40 mIU/mL,6 week postsurgical bilateral oophorectomy confirmation FSH &gt; 40 mIU/mL , surgical report ultrasound , 6 week postsurgical hysterectomy ovary failure confirm FSH &gt; 40 mIU/mL Age ≥40 year ; ≥35 bilateral oophorectomy Normal clinical breast exam negative mammogram ≥ 40 year age Negative urine pregnancy test ( nonhysterectomized &amp; &lt; 12 month amenorrhea Enrollment Sponsor 's Study PR04409 PR05812 Participation clinical trial use investigational drug within 30 day prior screen Known hypersensitivity estrogen &amp; /or progestin therapy Known suspect premalignant malignant disease history steroiddependent malignancy Manifestation treatment significant cardiovascular disease ( congestive heart failure , stroke ischemic attack , myocardial infarction , coronary artery bypass , percutaneous angioplasty &gt; 50 % angiographic narrowing coronary artery Thrombophlebitis thromboembolic disorder history Insulindependent diabetes mellitus Increased frequency severity headaches hormone estrogen therapy Currently take St. John 's Wort Drug/alcohol addiction within past 2 year Treatment anticoagulant ( heparin warfarin ) Smoking ≥15 cigarettes/day</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Vulvovaginal Atrophy</keyword>
	<keyword>Dyspareunia</keyword>
	<keyword>Postmenopausal</keyword>
</DOC>